Epiopharm Revenue
Pharmaceutical Manufacturing • 
Switzerland • 1-10 Employees
$
Epiopharm revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Epiopharm
Antonia Hirt
CEO
Company overview
| Headquarters | Switzerland |
| Website | |
| NAICS | 3254 |
| Employees | 1-10 |
About Epiopharm
Epiopharm GmbH is a pharmaceutical company working on first-in-class anti-inflammatory therapies to improve the lives of patients suffering from chronic inflammatory disease. The company therefore develops highly efficient small organic molecules with oral bioavailability.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Epiopharm has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Epiopharm has never raised funding before.
Czechia
United Kingdom
United States
France
AustraliaFrequently asked questions
Epiopharm is located in CH.
Epiopharm generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
Epiopharm has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Epiopharm has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
